Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Apr
7
2014
Stay Off My Turf! How to Protect Field of Use in a Biotechnology License Agreement Mintz
Jun
28
2016
California District Court Judge Issues TRO and Preliminary Injunction Under the Defend Trade Secrets Act Mintz
Jun
30
2016
Supreme Court Decides Two Key Aspects of IPR in Cuozzo Speed Techs LLC v. Lee Mintz
Aug
23
2016
Federal Circuit Emphasizes that an Obviousness Analysis Based on Common Sense Must be Supported by Substantial Evidence and Explained with Sufficient Reasoning Mintz
Aug
30
2016
Biosimilar FDA Approvals on Horizon As More States Enact Substitution Laws Mintz
Oct
3
2016
U.S. Supreme Court Denies Redskins’ Petition to Join SLANTS Case Mintz
Jun
30
2014
Trademark Rights around the World: It May Be BUDWEISER® in the US, But Not Everywhere Mintz
Jul
9
2020
The Standard May Rule Them All: Federal Circuit Panel Appears Prepared to Find Standard Is Sufficient to Prove Infringement for SEP Compliant Products Mintz
Nov
15
2016
Failure to Let Patent Owner Address Unpatentability Arguments Relied on by the Board Violates Administrative Procedures Mintz
Jul
28
2020
Fractured Federal Circuit Panel Finds That Sovereign Immunity Does Not Prevent Exclusive Licensee from Pursuing Unlicensed Infringement Alone Mintz
Dec
15
2016
Supreme Court to Hear Patent Venue Case Mintz
Dec
21
2016
USPTO Proposes Fee Increases for FY 2017 Mintz
Jan
6
2017
ClassCo, Inc. v. Apple, Inc.: A Reminder Of Obviousness Analysis Under KSR Mintz
Oct
15
2020
Fate of PTAB Judges and Decisions Now in Hands of Supreme Court Mintz
Feb
1
2017
PTAB Provides A Possible Roadmap For Patent Owners To Successfully Argue Secondary Considerations Of Nonobvious Mintz
Oct
1
2014
Marking of Patented Products in the UK Mintz
Jan
28
2021
Expediting Patent Prosecution After An Advisory Action Mintz
Mar
10
2021
Patent Buyers Beware: Supreme Court Ruling in Hologic May Merit Additional Contractual Protections Mintz
May
19
2017
You Can Not Claim What you Don’t Possess – Federal Circuit Holds Fiber Optic Claims Invalid under Section 112 Mintz
Mar
31
2021
Good News/Bad News: Patent Owners and Petitioners Both Make Gains in CAFC Uniloc Decision Mintz
Jun
20
2017
Matal v. Tam: U.S. Supreme Court Holds Prohibition on Disparaging Trademarks Unconstitutional under First Amendment Mintz
May
24
2021
How NFTs and Blockchain Secure Digital Sports Collectibles Mintz
Jun
16
2021
Reduced scope of march-in rights under Bayh Dole rules revisions Mintz
Feb
3
2015
Use It or Lose It: When Can a Trademark Registered Under Section 44(e) or 66(a) Be Deemed “Abandoned” in the US? Mintz
Sep
23
2021
EXCLUSIVE RIGHTS: Intellectual Property — Blockchain, Cryptocurrency, and IP: What Does the Future Hold? [PODCAST] Mintz
Mar
18
2015
Indiana Federal Court Denies Generic Drug Manufacturer’s Motion to Dismiss Hatch-Waxman Patent Infringement Action on Jurisdiction Grounds Mintz
Mar
21
2015
District Court Rules Against Amgen’s Motion for Preliminary Injunction to Prevent Marketing of Sandoz’s Biosimilar Zarxio Mintz
Mar
24
2015
Tips for Effectively Organizing PTAB Appeals Brief – Claim Grouping Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins